Ask AI
ProCE Banner Activity

Optimizing Primary Care Physicians’ Role in Managing sHTG and FCS

Clinical Thought

Primary care physicians are uniquely positioned to identify severe hypertriglyceridemia early, distinguish secondary causes from rare genetic conditions like FCS, and coordinate long-term care. With new therapies now available for FCS, timely recognition and collaboration with experienced specialists have become even more critical.

Released: December 23, 2025

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Ionis Pharmaceuticals.

Ionis Pharmaceuticals

Target Audience

This activity is intended for internal medicine and family medicine physicians, nurse practitioners, and physician associates who care for patients with sHTG, including FCS.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate the risks of severely elevated triglycerides in patients with FCS and the unmet therapeutic need in this population 

  • Assess the latest clinical safety and efficacy data on new and emerging therapies for sHTG and FCS

  • Identify the pathophysiological mechanisms and diagnostic criteria of severely elevated triglycerides, including FCS

Disclosure

Primary Author

Zahid Ahmad, MD: researcher: Ionis; other financial or material support: Amryt.